Skip to main content

Drug Safety

    Dr. Jack Cush presents his favorite abstracts and presentations from Rheumatology Round Up and ACR 2019. #1223  ALLN-346 a urate degrading enzyme in a pig model of gout L06 Emapalumab for treating…
    Romosozumab and Patients with Chronic Kidney Disease: Dr. Arthur Lau
    Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta.
    Inflammatory Arthritis Persists After Immunotherapy Cessation: Dr. David Liew
    Dr. Liew discusses abstract #1808 Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Persists After Immunotherapy Cessation presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
    Panel Presentation: Rheumatoid Arthritis
    Drs. Jack Cush, Arthur Kavanaugh and Jonathan Kay discuss several rheumatoid arthritis studies presented at the 2019 ACR/ARP Annual Meeting in Atlanta. Abstracts discussed include abstract #1342, #1350, #1160, and more.
    Safety of Methotrexate (The CIRT Trial): Dr. Jack Cush
    Dr. Cush discusses abstract #1890 on the CIRT trial as presented at the 2019 ACR/ARP annual meeting in Atlanta.
    Panel Presentation: What's New in iRAEs
    Drs. Laura Cappelli, Len Calabrese and Cassandra Calabrese discuss iRAE studies presented at the 2019 ACR/ARP annual meeting in Atlanta.
    FDA Update: Dr. Arthur Kavanaugh
    Dr. Kavanaugh gives an overview of the FDA Update session presented at the 2019 ACR/ARP Annual Meeting.
    Fibromyalgia Treatments: Dr. Philip Robinson
    Dr. Robinson highlights a 2019 ACR annual meeting session on fibromyalgia.
    Antimalarials in RA: Dr. Janet Pope
    Dr. Janet Pope discusses two abstracts - #1891 and #896 - regarding hydroxychloroquine in RA at the 2019 ACR/ARP annual meeting in Atlanta.
    Infection Prevention and Immunosuppression: Dr. Cassandra Calabrese
    Dr. Cassandra Calabrese gives an overview of a talk on infection prevention, vaccines and immunosuppression at the 2019 ACR/ARP annual meeting in Atlanta.